Antinephrin-Associated Primary Focal Segmental Glomerulosclerosis Successfully Treated With Plasmapheresis
Open Access
- 1 July 2024
- journal article
- editorial
- Published by Elsevier in Kidney International Reports
- Vol. 9 (9) , 2829-2831
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- A multi-institutional study found a possible role of anti-nephrin antibodies in post-transplant focal segmental glomerulosclerosis recurrenceKidney International, 2023
- Circulating nephrin autoantibodies and posttransplant recurrence of primary focal segmental glomerulosclerosisAmerican Journal of Transplantation, 2022
- Discovery of Autoantibodies Targeting Nephrin in Minimal Change Disease Supports a Novel Autoimmune EtiologyJournal of the American Society of Nephrology, 2022
- New Anti-Nephrin Antibody Mediated Podocyte Injury Model Using a C57BL/6 Mouse StrainNephron, 2017